Lung transcriptional unresponsiveness and loss of early influenza virus control in infected neonates is prevented by intranasal Lactobacillus rhamnosus GG
- PMID: 31603951
- PMCID: PMC6808501
- DOI: 10.1371/journal.ppat.1008072
Lung transcriptional unresponsiveness and loss of early influenza virus control in infected neonates is prevented by intranasal Lactobacillus rhamnosus GG
Abstract
Respiratory viral infections contribute substantially to global infant losses and disproportionately affect preterm neonates. Using our previously established neonatal murine model of influenza infection, we demonstrate that three-day old mice are exceptionally sensitive to influenza virus infection and exhibit high mortality and viral load. Intranasal pre- and post-treatment of neonatal mice with Lactobacillus rhamnosus GG (LGG), an immune modulator in respiratory viral infection of adult mice and human preterm neonates, considerably improves neonatal mice survival after influenza virus infection. We determine that both live and heat-killed intranasal LGG are equally efficacious in protection of neonates. Early in influenza infection, neonatal transcriptional responses in the lung are delayed compared to adults. These responses increase by 24 hours post-infection, demonstrating a delay in the kinetics of the neonatal anti-viral response. LGG pretreatment improves immune gene transcriptional responses during early infection and specifically upregulates type I IFN pathways. This is critical for protection, as neonatal mice intranasally pre-treated with IFNβ before influenza virus infection are also protected. Using transgenic mice, we demonstrate that the protective effect of LGG is mediated through a MyD88-dependent mechanism, specifically via TLR4. LGG can improve both early control of virus and transcriptional responsiveness and could serve as a simple and safe intervention to protect neonates.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Intranasal administration of Lactobacillus rhamnosus GG protects mice from H1N1 influenza virus infection by regulating respiratory immune responses.Lett Appl Microbiol. 2010 Jun 1;50(6):597-602. doi: 10.1111/j.1472-765X.2010.02844.x. Epub 2010 Mar 29. Lett Appl Microbiol. 2010. PMID: 20438620
-
Nasal priming with immunobiotic Lactobacillus rhamnosus modulates inflammation-coagulation interactions and reduces influenza virus-associated pulmonary damage.Inflamm Res. 2015 Aug;64(8):589-602. doi: 10.1007/s00011-015-0837-6. Epub 2015 Jun 14. Inflamm Res. 2015. PMID: 26072063
-
Oral administration of lactobacilli from human intestinal tract protects mice against influenza virus infection.Lett Appl Microbiol. 2010 Jul;51(1):6-10. doi: 10.1111/j.1472-765X.2010.02849.x. Epub 2010 Apr 5. Lett Appl Microbiol. 2010. PMID: 20438618
-
Neonatal hyperoxia alters the host response to influenza A virus infection in adult mice through multiple pathways.Am J Physiol Lung Cell Mol Physiol. 2013 Aug 15;305(4):L282-90. doi: 10.1152/ajplung.00112.2013. Epub 2013 Jun 7. Am J Physiol Lung Cell Mol Physiol. 2013. PMID: 23748535 Free PMC article.
-
Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.J Virol. 2017 Sep 12;91(19):e01050-17. doi: 10.1128/JVI.01050-17. Print 2017 Oct 1. J Virol. 2017. PMID: 28724768 Free PMC article.
Cited by
-
Synergy between Lactobacillus murinus and anti-PcrV antibody delivered in the airways to boost protection against Pseudomonas aeruginosa.Mol Ther Methods Clin Dev. 2024 Aug 30;32(4):101330. doi: 10.1016/j.omtm.2024.101330. eCollection 2024 Dec 12. Mol Ther Methods Clin Dev. 2024. PMID: 39314638 Free PMC article.
-
Engineered probiotic Escherichia coli elicits immediate and long-term protection against influenza A virus in mice.Nat Commun. 2024 Aug 9;15(1):6802. doi: 10.1038/s41467-024-51182-3. Nat Commun. 2024. PMID: 39122688 Free PMC article.
-
The Role of Gut Microbiome Supplementation in COVID-19 Management.Cureus. 2023 Oct 13;15(10):e46960. doi: 10.7759/cureus.46960. eCollection 2023 Oct. Cureus. 2023. PMID: 38021562 Free PMC article. Review.
-
Interferons-Implications in the Immune Response to Respiratory Viruses.Microorganisms. 2023 Aug 29;11(9):2179. doi: 10.3390/microorganisms11092179. Microorganisms. 2023. PMID: 37764023 Free PMC article. Review.
-
Nutrients, herbal bioactive derivatives and commensal microbiota as tools to lower the risk of SARS-CoV-2 infection.Front Nutr. 2023 Jun 1;10:1152254. doi: 10.3389/fnut.2023.1152254. eCollection 2023. Front Nutr. 2023. PMID: 37324739 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources